Mammography Provides Equal Benefits To Women In Their 40s: Tips Balance TowardAnnual Screening

May 31, 1998

Although breast cancer is more common after age 50, the benefit of detecting breast cancer through an annual screening mammogram is greater for a woman in her 40s than for an older woman, report researchers from the University of Chicago Medical Center in the June 1 issue of the journal, Cancer.

Cancers detected, at any age, by screening mammogram tend to be equally small, averaging about one centimeter in diameter. But for women in their 40s, cancers first noticed not on a mammogram but as a palpable lump tend to be larger, more aggressive, and more likely to have already spread to the nearby lymph nodes than for older women.

Consequently, "more older women benefit from mammography, but the younger women who benefit from mammography benefit more," said Ruth Heimann, M.D., Ph.D., professor of radiation and cellular oncology at the University of Chicago and director of the study. "Women under 50 with clinically rather than mammographically detected cancers have worse disease and worse outcomes than women over 50."

This finding "tips the scales, already leaning that way, a few more notches in favor of annual screening mammograms for women in their 40s," she adds.

For women with breast cancers detected via screening mammograms, 90 to 92 percent -- nine out of ten -- were alive and cancer-free five years later. For women 50 and older, with cancers detected on a clinical exam rather than by mammogram, disease-free survival fell only slightly, to 87 percent.

But for women 40 to 49 with breast cancers detected as lumps, five-year disease-free survival plunged to 77 percent -- about three out of four.

"Given time to grow big enough to be felt," explained Heimann, "the disease appears to be more aggressive in younger women. Breast tumors in women under 50 grow faster, establish their own blood supply more quickly, and are more likely to spread not just to nearby lymph nodes but to distant sites, making treatment more onerous and less effective."

The researchers -- Heimann and University of Chicago colleagues Jeffrey Bradley, M.D., and Samuel Hellman, M.D. -- followed 869 cases of women with Stage-I or Stage-II breast cancer who received breast-conserving therapy (BCT) at the University of Chicago Hospitals between 1984 and 1994. (BCT included lumpectomy and local radiation. Most node-positive patients also received chemotherapy, and about 40% received tamoxifen to prevent recurrence.)

Tumors detected by mammogram were virtually identical, whether women were in their 40s or older, with similar average size and grade, and similar rates of lymph-node spread and disease-free survival.

Tumors detected by clinical exam, however, were significantly more advanced for younger women. They were 33-percent larger (2 cm versus 1.5 cm), of a higher grade (36% grade-3 versus 25%), and more likely to have spread to axillary lymph nodes (31% versus 20%). With more advanced disease, survival rates decrease.

While critics of mammograms for younger women have emphasized the greater difficulty of detecting smaller tumors in the denser breasts of younger women, this study indicates that the principal alternative method for early detection, breast palpation, is also less effective in denser, pre-menopausal breasts.

"Although our data do not address the public policy or cost-effectiveness considerations of screening mammograms for women under 50, they do indicate that the benefit of mammography is not limited to older women," said Heimann.

"Breast cancer may be 50-percent more common for women in their 50s than for those in their 40s, but our data suggest that the life-extending benefits of early detection are more than 50-percent greater for women who get breast cancer in their 40s."

"From an individual young woman's point of view the clinical decision to get annual screening mammograms is no longer a 'toss up,' as some have suggested," concludes Heimann, "but a prudent choice."

Breast cancer is the leading cause of cancer death in women age 35 to 54. For every 100,000 women in their 40s, 162 will be diagnosed with breast cancer. For women in their 50s, that rises to 251, and for women over 65, to 450.

University of Chicago Medical Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to